FASEB J. Mp Biomedicals
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FARRÉ, L.
Right arrow Articles by MANGUES, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FARRÉ, L.
Right arrow Articles by MANGUES, R.
(The FASEB Journal. 2002;16:975-982.)
© 2002 FASEB

Heterotopic implantation alters the regulation of apoptosis and the cell cycle and generates a new metastatic site in a human pancreatic tumor xenograft model

LOURDES FARRÉ, ISOLDA CASANOVA, SÍLVIA GUERRERO, MANUEL TRIAS*, GABRIEL CAPELLÀ{dagger} and RAMON MANGUES1

Institut de Recerca and
* Department of Surgery of the Hospital de la Santa Creu i Sant Pau, Barcelona; and
{dagger} Laboratori de Recerca Translacional of the Institut Català d’Oncologia, Barcelona, Spain

1Correspondence: Institut de Recerca, Hospital de Sant Pau, Avda. Sant Antoni M. Claret, 167, Barcelona, Spain. E-mail: rmangues{at}santpau.es

Differences in growth and in response to antineoplastic drugs between s.c. and orthotopically implanted tumors in nude mice and between the primary tumor and the metastases in human tumors suggest that implantation site may alter the molecular regulation of tumor cells. We assessed the influence of implantation site on cell cycle and apoptotic regulation and the possible contribution of the implantation site in directing the choice of metastatic site by comparing the behavior of tumor aliquots of two human pancreatic xenografts (NP18 and NP9) implanted in the organ where the tumor grows (orthotopically), in heterotopic sites (the site of metastases (liver), and in nonmetastatic sites (subcutis and colon). We observed that implantation site changes tumor growth by altering apoptotic or cell cycle regulation in a tumor-specific manner. In the NP18 tumor it occurs by altering apoptotic induction and activation of the Bad/Bcl-XL/caspase-3 pathway through AKT and Erk regulation, but in the NP9 tumor by changing the activation and/or expression of the proteins that regulate the cell cycle (Erk, PCNA, and cyclin B1). We also observed that implantation site alters the metastatic pattern of the NP9 tumor, originating a new metastatic site.—Farré, L., Casanova, I., Guerrero, S., Trias, M., Capellà, G., Mangues, R. Heterotopic implantation alters the regulation of apoptosis and the cell cycle and generates a new metastatic site in a human pancreatic tumor xenograft model.


Key Words: implantation site • carcinoma • metastases




This article has been cited by other articles:


Home page
Cancer Res.Home page
M. Parreno, I. Casanova, M. V. Cespedes, J. P. Vaque, M. A. Pavon, J. Leon, and R. Mangues
Bobel-24 and Derivatives Induce Caspase-Independent Death in Pancreatic Cancer Regardless of Apoptotic Resistance
Cancer Res., August 1, 2008; 68(15): 6313 - 6323.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. V. Cespedes, C. Espina, M. A. Garcia-Cabezas, M. Trias, A. Boluda, M. T. Gomez del Pulgar, F. J. Sancho, M. Nistal, J. C. Lacal, and R. Mangues
Orthotopic Microinjection of Human Colon Cancer Cells in Nude Mice Induces Tumor Foci in All Clinically Relevant Metastatic Sites
Am. J. Pathol., March 1, 2007; 170(3): 1077 - 1085.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
M. Parreno, J. P. Vaque, I. Casanova, P. Frade, M. V. Cespedes, M. A. Pavon, A. Molins, M. Camacho, L. Vila, J. F. Nomdedeu, et al.
Novel triiodophenol derivatives induce caspase-independent mitochondrial cell death in leukemia cells inhibited by Myc
Mol. Cancer Ther., May 1, 2006; 5(5): 1166 - 1175.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. S. Duxbury, H. Ito, M. J. Zinner, S. W. Ashley, and E. E. Whang
Inhibition of Src Tyrosine Kinase Impairs Inherent and Acquired Gemcitabine Resistance in Human Pancreatic Adenocarcinoma Cells
Clin. Cancer Res., April 1, 2004; 10(7): 2307 - 2318.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by The Federation of American Societies for Experimental Biology.